300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Kyrgyzstan
LATAM
Africa
Oceania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Angels in MedCity, VC Fund

Angels in MedCity

VC Fund

London, United Kingdom

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Total investments:
19
Last investment:
Lead investor:
11%

Last updated:

Industries Angels in MedCity invests in

Health CareBiotechnologyMedicalLife ScienceMedical Device

Stages Angels in MedCity invests in

SeedFunding RoundAngelPre-SeedSeries A

Countries Angels in MedCity invests in

United KingdomUnited States

Round sizes

Seed $458k–$880k

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$458k–$880k

Investment Focus

Industry

  • Health Care 11 (58%)
  • Biotechnology 10 (53%)
  • Medical 6 (32%)
  • Life Science 6 (32%)
  • Medical Device 6 (32%)
See all 30 industries →

Stage

  • Seed 7 (37%)
  • Funding Round 5 (26%)
  • Angel 3 (16%)
  • Pre-Seed 1 (5%)
  • Series A 1 (5%)
See all 6 stages →

Country

  • United Kingdom 16 (84%)
  • United States 1 (5%)

Team

NameTitleInvestmentsLinksEmail
Nicholas Ibery
Nicholas Ibery Angel Investor
Angel Investor Total investments: 0
Find email
Patrick O'Brien
Patrick O'Brien Project Manager
Project Manager Total investments: 1
Find email
Patrick O'Brien
Patrick O'Brien Project Manager
Project Manager Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
Clustermarket is the world’s leading operating system for life-sciences laboratories. Our goal is to bring the management of research into the digital age, democratise access to expensive equipment and services and ultimately to enable life sciences innovators to get ideas to market faster than ever before. Our award-winning lab management software(previously known as Bookkit) and revolutionary marketplace helps labs to manage, connect and share resources. $1.1M / Angel / Nov 01, 2019
Clustermarket enables lab managers and operations teams to organize and schedule the use of shared equipment through a centralized system. Calira helps users replace manual tracking tools such as spreadsheets and shared calendars by offering real-time visibility into equipment availability, usage, and location. Its system supports efficientcoordination among research teams, reducing scheduling conflicts and downtime. $1.2M / Angel / Nov 01, 2019
Atelerix has a transformative technology for the storage and transport of viable cells at room temperature, overcoming the barriers and limitations presented by the current need for cryo-shipping. We do this using our patented process of encapsulating the cells in a natural hydrogel for safe shipment and storage. The cells can be recovered whenneeded by the addition of a gentle, cell-friendly buffer. This means: Predictability and reliability in drug discovery models and for cells used as therapies Customers can use cells and assays immediately on arrival No need for cryopreservation, nor need for cytotoxic or animal-derived supplements Cells retain their natural state and are not damaged nor altered $458K / Seed / Apr 30, 2018
DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses. $880K / Seed / Apr 28, 2017
Clustermarket is the world’s leading operating system for life-sciences laboratories. Our goal is to bring the management of research into the digital age, democratise access to expensive equipment and services and ultimately to enable life sciences innovators to get ideas to market faster than ever before. Our award-winning lab management software(previously known as Bookkit) and revolutionary marketplace helps labs to manage, connect and share resources. Angel / Apr 13, 2017
LiveSmart provides health assessments and reacted quickly to the new situation. The team sourced and supplied antibody tests via their well-established platform; supporting both small businesses and large corporate clients. Seed / Mar 29, 2017
Accurx is where conversations happen with and about patients. Through one, easy-to-use platform, we help everyone involved in a patient’s care to communicate and collaborate.Whether you’re a patient or a healthcare professional, Accurx lets you connect seamlessly with the people you need to. You can use Accurx to: send SMS messages and medicalsurveys, provide appointment reminders and referrals, hold video consultations, and manage virtual wards, outpatient clinics and follow-up pathways.Accurx is used by 98% of GP practices and in 50% of NHS trusts. Pre-Seed / Mar 17, 2017
The Electrospinning Company is a leading edge provider of electrospun nanofibre innovations, developing solutions to industrial challenges. They also work closely with academic research groups to develop novel nano-scale fibres and coatings for scientific research. Angel / Feb 01, 2017
Jupiter Diagnostics offers a faster, cheaper way to obtain accurate blood tests. Our patent- protected reader can replace the lab, delivering multiple tests in 10 minutes, from a prick of blood, at prices a third cheaper. $2.1M / Jan 23, 2017
Jupiter Diagnostics offers a faster, cheaper way to obtain accurate blood tests. Our patent- protected reader can replace the lab, delivering multiple tests in 10 minutes, from a prick of blood, at prices a third cheaper. Seed / Jan 23, 2017
See all 19 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Kyrgyzstan
LATAM
Africa
Oceania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Angels in MedCity invest in?

Angels in MedCity invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Funding Round stage. Most of the 19 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Angels in MedCity's check size?

Angels in MedCity typically joins rounds of $458k–$880k at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Angels in MedCity participates in.

How do I contact Angels in MedCity?

Public channels for Angels in MedCity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Angels in MedCity?

The team at Angels in MedCity includes Nicholas Ibery (Angel Investor), Patrick O'Brien (Project Manager) and Patrick O'Brien (Project Manager). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Angels in MedCity Angels in MedCity Find emails